|
Wysocka, Maria; Zaki, Mohamed H; French, Lars E et al. (2002) Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines. Blood 100:3287-94
|
|
Wysocka, M; Robertson, S; Riemann, H et al. (2001) IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J Immunol 166:7504-13
|
|
Trinchieri, G; Scott, P (1999) Interleukin-12: basic principles and clinical applications. Curr Top Microbiol Immunol 238:57-78
|
|
Marshall, J D; Chehimi, J; Gri, G et al. (1999) The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood 94:1003-11
|
|
Kubin, M Z; Parshley, D L; Din, W et al. (1999) Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48. Eur J Immunol 29:3466-77
|
|
Fox, F E; Kubin, M; Cassin, M et al. (1999) Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cells. J Interferon Cytokine Res 19:407-15
|
|
Aste-Amezaga, M; Ma, X; Sartori, A et al. (1998) Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol 160:5936-44
|
|
Ma, X; Riemann, H; Gri, G et al. (1998) Positive and negative regulation of interleukin-12 gene expression. Eur Cytokine Netw 9:54-64
|
|
Schwarz, A; Grabbe, S; Mahnke, K et al. (1998) Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CD8+ rather than CD4+ T cells. J Invest Dermatol 110:272-6
|
|
Karp, C L; Wysocka, M; Ma, X et al. (1998) Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol 28:3128-36
|
Showing the most recent 10 out of 105 publications
